Cellular and humoral immunity after the third dose of SARS-CoV-2 vaccine in patients treated with rituximab.
Lancet Rheumatol
; 4(1): e13-e16, 2022 Jan.
Article
in English
| MEDLINE | ID: covidwho-1510519
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Topics:
Vaccines
Language:
English
Journal:
Lancet Rheumatol
Year:
2022
Document Type:
Article
Affiliation country:
S2665-9913(21)00351-9
Similar
MEDLINE
...
LILACS
LIS